Effect of complementary and alternative medicine on the survival and health-related quality of life among terminally ill cancer patients: A prospective cohort study

Annals of Oncology

Volumn 24, Issue 2, 2013, Pages 489-494

  Yun, Y H ^a   Lee, M K ^b   Park, S M ^a   Kim, Y A ^b   Lee, W J ^b   Lee, K S ^b   Choi, J S ^c   Jung, K H ^d   Do, Y R ^e   Kim, S Y ^f   Heo, D S ^g   Kim, H T ^b   Park, S R ^b  

^a Seoul National University Hospital   (South Korea)

^b National Cancer Center   (South Korea)

^c Gangneung Asan Hospital   (South Korea)

^d University of Ulsan College of Medicine   (South Korea)

^e Dongsan Medical Center   (South Korea)

^f Chungnam National University College of Medicine   (South Korea)

^g Seoul National University College of Medicine   (South Korea)

Author keywords

Alternative medicine; Cancer; Complementary medicine; HRQOL; Prospective cohort; Terminal illness

Indexed keywords

ADULT; AGED; ALTERNATIVE MEDICINE; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; COGNITION; COHORT ANALYSIS; CONTROLLED STUDY; DIETARY INTAKE; FATIGUE; FEMALE; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RELIGION; TERMINAL DISEASE; UNIVERSITY HOSPITAL; VITAMIN SUPPLEMENTATION;

EID: 84873832413     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mds469     Document Type: Article

References (29)

1. Cassileth B. Complementary therapies: The American experience. Support Care Cancer 2000; 8: 16-23.
2. Eisenberg DM, Davis R, Ettner SL et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 1998; 280: 1569-1575.
3. DiGianni LM, Garber J, Winer EP. Complementary and alternative medicine use among women with breast cancer. J Clin Oncol 2002; 20: 34S-48S.
4. Kim SG, Park EC, Park JH et al. Initiation and discontinuation of complementary therapy among cancer patients. J Clin Oncol 2007; 25: 5267-5274.
5. Hyodo I, Amano N, Eguchi K et al. Nationwide survey on complementary and alternative medicine in cancer patients in Japan. J Clin Oncol 2005; 23: 2645-2654.
6. Cassileth BR, Vickers AJ. High prevalence of complementary and alternative medicine use among cancer patients: implications for research and clinical care. J Clin Oncol 2005; 23: 2590-2592.
7. McDermott CL, Blough DK, Fedorenko CR et al. Complementary and alternative medicine use among newly diagnosed prostate cancer patients. Support Care Cancer 2010; 20: 65-73.
8. Cleeland CS. Symptom burden: Multiple symptoms and their impact as patientreported outcomes. J Natl Cancer Inst 2007; 37: 16-21.
9. Hlubocky FJ, Ratain MJ, Wen M et al. Complementary and alternative medicine among advanced cancer patients enrolled on phase I trials: a study of prognosis, quality of life, and preferences for decision making. J Clin Oncol 2007; 25: 548-554.
10. Pfister DG, Cassileth BR, Deng GE et al. Acupuncture for pain and dysfunction after neck dissection: results of a randomized controlled trial. J Clin Oncol 2010; 28: 2565-2570.
11. Ezzo J, Vickers A, Richardson MA et al. Acupuncture-point stimulation for chemotherapy-induced nausea and vomiting. J Clin Oncol 2005; 23: 7188-7198.
12. Barton DL, Soori GS, Bauer BA et al. Pilot study of Panax quinquefolius (American ginseng) to improve cancer-related fatigue: a randomized, doubleblind, dose-finding evaluation: NCCTG trial N03CA. Support Care Cancer 2010; 18: 179-187.
13. Schofield P, Diggens J, Charleson C et al. Effectively discussing complementary and alternative medicine in a conventional oncology setting: communication recommendations for clinicians. Patient Educ Couns 2010; 79: 143-151.
14. Yun YH, Kwon YC, Lee MK et al. Experiences and attitudes of patients with terminal cancer and their family caregivers toward the disclosure of terminal illness. J Clin Oncol 2010; 28: 1950-1957.
15. National Cancer for Complementary and Alternative Medicine (NCCAM). (2008). CAM Basics: What is CAM? (p. 1). Retrieved August 13, 2008, from http://nccam.nih.gov/health/whatiscam.
16. Yun YH, Park YS, Lee ES et al. Validation of the Korean version of the EORTC QLQ-C30. Qual Life Res 2004; 13: 863-868.
17. Robins JM, Hernan MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology 2000; 11: 550-560.
18. Fayers PM, Aaronson N, Bjordal K et al. The EORTC QLQ-C30 scoring manual, 3rd edition. Brussels, Belgium: European Organization for Research and Treatment of Cancer 2001
19. Fayers PM. Interpreting quality of life data: population-based reference data for the EORTC QLQ-C30. Eur J Cancer 2001; 37: 1331-1334.
20. Corbin LW, Mellis BK, Beaty BL et al. The use of complementary and alternative medicine therapies by patients with advanced cancer and pain in a hospice setting: a multicentered, descriptive study. J Palliat Med 2009; 12: 7-8.
21. Wyatt G, Sikorskii A, Wills CE et al. Complementary and alternative medicine use, spending, and quality of life in early stage breast cancer. Nurs Res 2010; 59: 58-66.
22. Frenkel M, Ben-Arye E, Cohen L. Communication in cancer care: discussing complementary and alternative medicine. Integr Cancer Ther 2010; 9: 177-185.
23. Han E, Johnson N, DelaMelena T et al. Alternative therapy used as primary treatment for breast cancer negatively impacts outcomes. Ann Surg Oncol 2011; 18: 912-916.
24. Kristoffersen AE, Fonnebo V, Norheim AJ. Do cancer patients with a poor prognosis use complementary and alternative medicine more often than others? J Altern Complement Med 2009; 15: 35-40.
25. Montazeri A, Sajadian A, Ebrahimi M et al. Depression and the use of complementary medicine among breast cancer patients. Support Care Cancer 2005; 13: 339-342.
26. McCulloch M, Broffman M, van der Laan M et al. Colon cancer survival with herbal medicine and vitamins combined with standard therapy in a wholesystems approach: ten-year follow-up data analyzed with marginal structural models and propensity score methods. Integr Cancer Ther 2011; 10: 240-259.
27. Crew KD, Capodice JL, Greenlee H et al. Randomized, blinded, sham-controlled trial of acupuncture for the management of aromatase inhibitor-associated joint symptoms in women with early-stage breast cancer. J Clin Oncol 2010; 28: 1154-1160.
28. Deng G, Vickers A, Yeung S et al. Randomized, controlled trial of acupuncture for the treatment of hot flashes in breast cancer patients. J Clin Oncol 2007; 25: 5584-5590.
29. Moadel AB, Shah C, Wylie-Rosett J et al. Randomized controlled trial of yoga among a multiethnic sample of breast cancer patients: effects on quality of life. J Clin Oncol 2007; 25: 4387-4395.